Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Non-Current Liabilities (2019 - 2025)

Bioadaptives' Other Non-Current Liabilities history spans 7 years, with the latest figure at $967406.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $967406.0; the TTM value through Sep 2025 reached $967406.0, changed N/A, while the annual FY2024 figure was $1.1 million, 7.71% up from the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $967406.0 at Bioadaptives, up from $860636.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.1 million in Q4 2024 and bottomed at $120000.0 in Q3 2021.
  • The 5-year median for Other Non-Current Liabilities is $860636.0 (2025), against an average of $771895.1.
  • The largest annual shift saw Other Non-Current Liabilities tumbled 84.02% in 2021 before it skyrocketed 42.37% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $557042.0 in 2021, then rose by 23.3% to $686856.0 in 2022, then surged by 42.37% to $977872.0 in 2023, then grew by 7.71% to $1.1 million in 2024, then decreased by 8.15% to $967406.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Other Non-Current Liabilities are $967406.0 (Q3 2025), $860636.0 (Q2 2025), and $991590.0 (Q1 2025).